AHAlexandra L. Hohmann

Alexandra L. Hohmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandra L. Hohmann has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Kneeling After Total Knee Arthroplasty: Does Resurfacing the Patella Affect the Ability to Kneel?

    by Alexandra L. Hohmann, Hannah Bash, Cristian A. DeSimone, Andrew Fraval, Jess H. Lonner

  • Social Determinants of Health Disparities Are Associated With Prolonged Opioid Utilization After Total Joint Arthroplasty

    by Alexandra L. Hohmann, Harrison S. Fellheimer, Samantha S. Meacock, Juan D. Lizcano, James J. Purtill, Yale A. Fillingham

  • Patients Utilizing Opioids Before Total Joint Arthroplasty Have Greater Social Determinants of Health Deficits than Opioid-Naïve Patients

    by Alexandra L. Hohmann, Juan D. Lizcano, Samantha S. Meacock, Elizabeth A. Abe, James J. Purtill, Yale A. Fillingham


  • Comparison of Survivorship of Distal Femoral Replacements by the Fixation Method

    by Alexandra L. Hohmann, Nihir Parikh, Jessica H. Leipman, Alan D. Lam, Alexandra S. Gabrielli, Chad A. Krueger, Yale A. Fillingham


  • Dalí Sign: Characterization and Case Series of Patellar Bony Shell Morphological Changes after Two-Stage Revision for Periprosthetic Joint Infection

    by Alexandra L. Hohmann, Cristian A. DeSimone, Jessica H. Leipman, Yale A. Fillingham, Jess H. Lonner

    The fate of the patella in two-stage revision total knee arthroplasty (TKA) for periprosthetic joint infection (PJI) in which the patella is left as a bony shell is poorly described. The purpose of this case series is to describe a phenomenon we name the Dalí Sign, which is characterized by elongation and curvature of the patella around the lateral edge of the femoral component occasionally observed in patients undergoing two-stage revision without reimplantation of the patellar component.Our institutional surgical database was queried for patients who were treated with two-stage revision arthroplasty for PJI by the two senior authors. All available sequential skyline patellar radiographs were viewed from immediately prior to first-stage explantation to latest image at final outpatient follow-up at our institution and assessed for the abovementioned morphological changes.Included patients underwent a two-stage revision surgery for PJI at our institution, had a patellar component removed during the first stage of their treatment which included implant explantation and insertion of temporary antibiotic spacers, did not have the patellar component reimplanted during their second-stage revision surgery, and demonstrated radiographic patellar morphological changes at final follow-up. Patients' demographic, surgical, and outcome data were recorded.Our review identified six patients meeting these criteria. Mean follow-up after second-stage surgery was 12 months (range 2 to 21 months). At final follow-up, three patients were walking without pain, one patient was exercising to tolerance, one patient was walking with pain, and one was using a wheelchair or a walker for mobility.In this case series, we characterize the Dalí Sign, the elongation and curvature of the patellar bony shell over the femoral component after two-stage revision for PJI. Further comparative cohort studies are necessary to identify the incidence and risk factors for the development of this morphological change and to compare outcomes of patients with and without the Dalí Sign when left with a bony shell after staged revision TKA.

  • Discrepancies in Periprosthetic Joint Infection Diagnostic Criteria Reporting and Use: A Scoping Review and Call for a Standard Reporting Framework

    by Alexandra L. Ba Hohmann, Cristian A. BS DeSimone, Natalie A. Lowenstein, Carl Deirmengian, Yale A. Fillingham

    Background: Numerous criterion-based definitions of periprosthetic joint infection (PJI) with differing criteria and point systems have been published, but the frequency of their use or application to study methods in publications on PJI has not been evaluated. Assessing the use of these definitions in studies is an important step to ensuring the validity and reproducibility of PJI research and to determining best practices for the application of these definitions in future research. Questions/purposes: As a scoping review, we identified and evaluated studies published since 2012 that defined PJI, and we asked: (1) Which of those definitions are cited most frequently in other peer-reviewed publications? (2) How often are the definition criteria and scoring systems reported in the methods beyond the name or citation or modified from the published definition? (3) How often did the PJI definition stated in a citing study’s methods section fail to align with the definition provided in the cited source? Methods: To identify published PJI definition citations, we queried PubMed for studies on PJI published between January 1, 2012, and August 1, 2023, identifying 75 unique citations in studies with human patients diagnosed with PJI. This study focused on PJI definitions detailing specific clinical and laboratory criteria for PJI, recognizing and including six formal definitions for PJI presented across 16 publications: the 2011 Musculoskeletal Infection Society (MSIS), 2013 MSIS/International Consensus Meeting (ICM), 2013 Infectious Disease Society of America (IDSA), 2018 ICM, and 2021 European Bone and Joint Infection Society (EBJIS) definitions, and an unendorsed 2018 Definition. Back citation of these 16 publications identified 457 studies (Journal of Arthroplasty n = 285, Clinical Orthopaedics and Related Research n = 69, Bone and Joint Journal n = 58, Journal of Bone and Joint Surgery n = 45) published between January 1, 2012, and December 31, 2022, that cited one of the identified PJI definition citations. Trends in PJI definition citation and reporting were assessed based on the following criteria: (1) the PJI definition claimed in the methods, (2) the cited reference to this claim, (3) the description of the definition in the manuscript, and (4) the definition modification. Results: Of 457 studies published between 2012 and 2022 that cited at least one PJI definition, the most cited was the 2011 MSIS definition (40% [183 studies]), followed by the 2013 MSIS/ICM definition (30% [139]), the unendorsed 2018 Definition (14% [65]), the 2018 ICM definition (3.7% [17]), the 2013 IDSA definition (3.5% [16]), and the 2021 EBJIS definition (one study); 7.9% (36) cited multiple definitions. Overall, 31% (141 of 457) of studies detailed the PJI definition beyond its name and citation. Authors modified definitions in 18% (83 of 457) of studies. Of the 98 studies using a definition with an inconclusive category, 18% (18 of 98) provided details on the inconclusive group. The PJI definition stated in the methods section did not align with the cited source in 19% (86 of 457) of studies. Of these, 85% (73 of 86) cited the unendorsed 2018 Definition while claiming use of an endorsed definition. Conclusion: The 2011/2013 MSIS definitions of PJI remain commonly cited through 2022 despite the availability of newer definitions. Many studies on PJI definitions suffer from a lack of methodological transparency, hindering both reproducibility and the assessment of their validity. There also exists an alarming rate of citation errors and widespread use of unendorsed scoring systems despite claims of adherence to accepted standards, representing a systematic error in the existing scientific record. Clinical Relevance: In response to these findings, we recommend that academic societies establish a standard reporting framework and checklist for studies using formal PJI definitions, such as those that exist for systematic reviews (Preferred Reporting Items for Systematic Reviews and Meta-Analyses [PRISMA]), randomized trials (Consolidated Standards of Reporting Trials [CONSORT]), and observational studies (Strengthening the Reporting of Observational Studies in Epidemiology [STROBE]). The MSIS and EBJIS, as discussed in an accompanying letter to the editor, are creating an endorsed standard reporting framework that aims to improve reporting transparency in the PJI research.


  • Undergoing cartilage procedures before total knee arthroplasty is not associated with worse postoperative functional outcomes, readmission rates or complication rates

    by Irfan A. Khan, Nicholas F. Cozzarelli, Alexandra L. Hohmann, Hassan Siddiqui, Fotios P. Tjoumakaris, Kevin B. Freedman, Yale A. Fillingham

    Purpose: Patients undergoing total knee arthroplasty (TKA) with prior knee cartilage surgery have unclear outcomes in the literature. This study compared outcomes after TKA in patients with or without prior knee cartilage surgery, and we hypothesized there would be equivocal outcomes between groups. Methods: A retrospective matched case–control study was conducted on patients from our institution who underwent ipsilateral cartilage procedure(s) and TKA (cases) or TKA alone (controls) from 2000 to 2022. Cartilage procedures included Autologous Chondrocyte Implantation (ACI), Osteochondral Allograft (OCA) and Microfracture (MFx). Matching was performed in 1:3 (case:control) ratio for age, sex, body mass index, Charlson Comorbidity Index, pre‐TKA Kellgren–Lawrence osteoarthritis grade and follow‐up for knee injury and osteoarthritis outcome score for joint replacement (KOOS‐JR). Mann–Whitney U and χ 2 analyses were conducted, with significance being a p  < 0.05. A priori power analysis required 29 patients per cohort to reach a clinically detectable difference of 11 for KOOS‐JR. Results: Forty‐three cases (one ACI, eight OCA and 34 MFx) and 129 controls were included after matching, with no significant demographic differences. Cases underwent TKA after cartilage surgery at a mean of 4.6 years. No significant differences existed between cases and controls for the preoperative KOOS‐JR (45.2 vs. 47.8; p = 0.353), postoperative KOOS‐JR (69.8 vs. 69.9; p = 0.974) or Delta KOOS‐JR (30.4 vs. 26.0; p = 0.387). No significant differences existed for 90‐day readmission rates (4.7% vs. 2.3%; p = 0.600) or revision TKA rates (11.6% vs. 5.4%; p = 0.177). Conclusion: Patients with and without prior cartilage surgery experience similar functional outcomes, readmission rates and revision rates after TKA on the same knee. Patients who are candidates for TKA with a history of cartilage surgery may be counselled that their surgical history on that knee does not convey the risk of worse functional outcomes. Level of Evidence: Level III case–control study.


  • Fragility Index Analysis of the 2018 Clinical Practice Guidelines on Tranexamic Acid Use in Total Joint Arthroplasty

    by Alexandra L. Hohmann, Alan E. Wilson, Danielle M. Schulte, Francisco D. Casambre, Craig J. Della Valle, Jess H. Lonner, Yale A. Fillingham


  • Does the Addition of a Tibial Stem Extender in Total Knee Arthroplasty Decrease Risk of Aseptic Loosening in Patients with Obesity? An Analysis from the American Joint Replacement Registry

    by Alexandra L. Hohmann, Alexander A. Linton, Brooke R. Olin, Gabriel L. Furey, Isabella Zaniletti, Ayushmita De, Yale A. Fillingham

    Mechanical loosening is a leading cause of failure of total knee arthroplasties (TKAs) for which obesity may be a risk factor. With rising rates of obesity and increasing incidence of TKA, the identification of factors to mitigate this cause of failure is necessary. The purpose of this study is to determine if the use of a tibial stem extender (TSE) decreases the risk of mechanical loosening in patients with obesity undergoing TKA. The American Joint Replacement Registry and linked Centers for Medicare & Medicaid Services claims database were utilized to identify a patient cohort with a body mass index (BMI) of 30 kg/m2 or greater and age 65 years or older who underwent primary elective TKA between 2012 and 2021. Patients were divided into cohorts based on obesity class and TSE utilization. The estimated association of TSE use, BMI categories, and covariates with the risk of revisions for mechanical loosening in both unadjusted and adjusted settings was determined. Hazard ratios and their 95% confidence intervals for the risk of mechanical loosening were calculated. A total of 258,775 TKA cases were identified. A total of 538 of 257,194 (0.21%) patients who did not receive a TSE and one patient out of 1,581 (0.06%) with a TSE were revised for mechanical loosening. In adjusted analysis, TSE use was not protective against mechanical loosening and BMI > 40 was not a significant risk factor. Use of a TSE was not found to be protective against mechanical loosening in patients with obesity; however, analysis was limited by the small number of outcome events in the cohort. Further analysis with a larger cohort of patients with TSE and a longer follow-up time is necessary to corroborate this finding.


  • Open Access

    Fragility analysis and systematic review of patellar resurfacing versus non‐patellar resurfacing in total knee arthroplasty

    by Teja Polisetty, Alexandra L. Hohmann, Eric DiDomenico, Jess H. Lonner

    Introduction: Fragility analysis is a method of further characterising the robustness of statistical outcomes. This study evaluates the statistical fragility of randomised controlled trials (RCTs) comparing patellar resurfacing versus non‐patellar surfacing in total knee arthroplasty (TKA).Methods: PubMed, MEDLINE and EMBASE were searched for RCTs comparing outcomes in TKA based on patellar resurfacing. Fragility index (FI) and reverse FI (collectively, “FI”) were calculated for dichotomous outcomes as the number of outcome reversals needed to change statistical significance. Fragility quotient (FQ) was calculated by dividing the FI by the sample size for that outcome. Median FI and FQ were calculated for each individual outcome and for the overall study. Subanalyses were performed to assess FI and FQ based on outcome type, statistical significance and loss to follow‐up.Results: Twenty‐one RCTs were included in the analysis, capturing 3910 subjects. The overall median FI was 5.0 (interquartile range, [IQR] 4.0−6.0), and the overall median FQ was 0.048 (IQR 0.022−0.065). The outcome of anterior knee pain has a median FI of 6.0 (IQR 4.0−6.0) and a median FQ of 0.057 (IQR 0.025−0.065). Only five (7%) outcomes were significant. The loss to follow‐up was greater than the FI in 12 of 19 studies (63%) with available data.Conclusion: RCTs comparing patellar resurfacing in TKAs show significant statistical fragility; a few outcome reversals can alter findings. The majority of outcomes were nonsignificant, indicating that the choice to resurface the patella may not affect most clinical outcomes; however, clinical conclusions are limited by the statistical fragility of the analysed outcomes. Larger RCTs for this comparison are necessary, and we suggest adding FI and FQ to RCT reports with p values to improve the interpretability of results.Level of Evidence: Level II.